Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
出版年份 2020 全文链接
标题
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
作者
关键词
-
出版物
Cancers
Volume 12, Issue 9, Pages 2482
出版商
MDPI AG
发表日期
2020-09-02
DOI
10.3390/cancers12092482
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
- (2020) Lisi Ma et al. Frontiers in Oncology
- Drug uptake-based chemoresistance in breast cancer treatment
- (2020) Helena Muley et al. BIOCHEMICAL PHARMACOLOGY
- Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
- (2020) Elizabeth Varghese et al. Cancers
- Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
- (2020) Jason R Brown et al. JCI Insight
- “Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy
- (2019) Marco Fiorillo et al. Frontiers in Oncology
- TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis
- (2019) Alec N. Woosley et al. ONCOGENE
- Efficacious Dose of Metformin for Breast Cancer Therapy is Determined by Cation Transporter Expression in Tumors
- (2019) Hao Cai et al. BRITISH JOURNAL OF PHARMACOLOGY
- The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials
- (2019) J. Rahmani et al. Clinical & Translational Oncology
- A Novel Mechanism of High Dose Radiation Sensitization by Metformin
- (2019) Stephen L. Brown et al. Frontiers in Oncology
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer stigma and cancer screening attendance: a population based survey in England
- (2019) Charlotte Vrinten et al. BMC CANCER
- Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
- (2019) Claudia Christowitz et al. BMC CANCER
- Metformin in breast cancer: preclinical and clinical evidence
- (2019) Anindita De et al. CURRENT PROBLEMS IN CANCER
- Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
- (2019) Weige Tan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
- (2019) Ji-Chang Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
- (2019) Maria Laura De Angelis et al. Frontiers in Oncology
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
- (2019) Loh et al. Cells
- Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
- (2019) Jiaojiao Zhou et al. Frontiers in Oncology
- Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
- (2019) De Angelis et al. Cancers
- Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy
- (2019) Samson Mathews Samuel et al. Cancers
- Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
- (2019) Sangita Sridharan et al. Frontiers in Oncology
- Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
- (2019) Snehal K. Shukla et al. Pharmaceutics
- Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
- (2019) Samson Mathews Samuel et al. Biomolecules
- A Convergence-Based Framework for Cancer Drug Resistance
- (2018) David J. Konieczkowski et al. CANCER CELL
- Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma
- (2018) Nobufumi Sekino et al. CANCER SCIENCE
- Randomized multicenter phase II trial of neoadjuvant therapy comparing weekly nab-paclitaxel followed by FEC with docetaxel followed by FEC in HER2-negative early-stage breast cancer
- (2018) Takashi Kuwayama et al. Clinical Breast Cancer
- Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
- (2018) Deli Hong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells
- (2018) Shahrzad Javidfar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
- (2018) Sen Xu et al. MOLECULAR CANCER THERAPEUTICS
- Aspirin and metformin exhibit antitumor activity in murine breast cancer
- (2018) Maoyuan Zhao et al. ONCOLOGY REPORTS
- Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles
- (2018) Vahid Shafiei-Irannejad et al. PHARMACEUTICAL RESEARCH
- Functional miRNAs in breast cancer drug resistance
- (2018) Weizi Hu et al. OncoTargets and Therapy
- Breast cancer stem cell-like cells generated during TGFβ-induced EMT are radioresistant
- (2018) Julie Konge et al. Oncotarget
- Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells
- (2018) Yuan-Chiang Chung et al. Scientific Reports
- Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects
- (2018) Sara Baldassari et al. Scientific Reports
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- Challenges and perspectives in the treatment of diabetes associated breast cancer
- (2018) Samson Mathews Samuel et al. CANCER TREATMENT REVIEWS
- Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK-1-eIF4G-eIF4E signaling
- (2018) Peng Shen et al. Molecular Oncology
- Breast cancer stem cells: Features, key drivers and treatment options
- (2018) Jürgen Dittmer SEMINARS IN CANCER BIOLOGY
- The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
- (2018) Elizabeth Varghese et al. Cancers
- Novel application of metformin combined with targeted drugs on anticancer treatment
- (2018) Jun Deng et al. CANCER SCIENCE
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- Bacterial infections and cancer
- (2018) Daphne van Elsland et al. EMBO REPORTS
- Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study
- (2018) Marissa C. van Maaren et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Cancer Stem Cells to Overcome Chemoresistance
- (2018) Toni Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
- (2018) Sara R. Martins-Neves et al. PHARMACOLOGICAL RESEARCH
- Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis
- (2018) Mingyue Rao et al. Cancer Management and Research
- Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
- (2018) Arindam Banerjee et al. CARCINOGENESIS
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model
- (2017) Camila Leonel et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Transporters Involved in Metformin Pharmacokinetics and Treatment Response
- (2017) Xiaomin Liang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments
- (2017) Georg Fluegen et al. NATURE CELL BIOLOGY
- Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
- (2017) Gerald Davies et al. PLoS One
- Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells
- (2017) Feixue Feng et al. Oncology Letters
- Suppression of Nrf2 Activity by Chestnut Leaf Extract Increases Chemosensitivity of Breast Cancer Stem Cells to Paclitaxel
- (2017) Yaejin Woo et al. Nutrients
- A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer
- (2017) Yannan Zhao et al. Oncotarget
- Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP
- (2017) Xuedong Wang et al. Oncotarget
- MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
- (2017) Qing Xie et al. Oncotarget
- Inhibition of FAK kinase activity preferentially targets cancer stem cells
- (2017) Vihren N. Kolev et al. Oncotarget
- Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells
- (2017) Pritha Mukherjee et al. Scientific Reports
- Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
- (2017) Raana Farajzadeh et al. Artificial Cells Nanomedicine and Biotechnology
- Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
- (2017) Zong-Sheng Jiang et al. Journal of Cancer
- Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
- (2017) Pedro M. Aponte et al. Stem Cells International
- Targeting MYC Dependence by Metabolic Inhibitors in Cancer
- (2017) Himalee S. Sabnis et al. Genes
- Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
- (2017) Peiguo Shi et al. Cell Discovery
- Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
- (2016) C. R. Triggle et al. Acta Physiologica
- Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence
- (2016) Nicole Noren Hooten et al. AGING CELL
- Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells
- (2016) Rong Sun et al. BIOMATERIALS
- Tumor microenvironment-mediated chemoresistance in breast cancer
- (2016) Kobra velaei et al. BREAST
- PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
- (2016) D. Samanta et al. CANCER RESEARCH
- Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
- (2016) Shilpi Saha et al. CANCER RESEARCH
- Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer
- (2016) Long Chen et al. CELL CYCLE
- Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer
- (2016) Reema Wahdan-Alaswad et al. CELL CYCLE
- Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells
- (2016) Hao Cai et al. INTERNATIONAL JOURNAL OF CANCER
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity
- (2016) Yu-Feng Zou et al. Molecular Medicine Reports
- Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors
- (2016) Veronika Mamaeva et al. MOLECULAR THERAPY
- Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
- (2016) JINKYOUNG KIM et al. ONCOLOGY REPORTS
- miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7
- (2016) Wei Zhao et al. ONCOLOGY REPORTS
- Molecular targets of metformin antitumor action
- (2016) Stanisław Sośnicki et al. Pharmacological Reports
- Metformin: An anti-diabetic drug to fight cancer
- (2016) Marie Daugan et al. PHARMACOLOGICAL RESEARCH
- Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
- (2016) Sai A. Balaji et al. PLoS One
- Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance
- (2016) Fengsheng Li et al. Oncology Letters
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications
- (2016) Xiewan Chen et al. Oncotarget
- PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis
- (2016) Olga Karicheva et al. Oncotarget
- Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer
- (2016) Rae-Kwon Kim et al. Oncotarget
- NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer
- (2016) Karla Vazquez-Santillan et al. Scientific Reports
- The hedgehog pathway in triple-negative breast cancer
- (2016) Joyce G. Habib et al. Cancer Medicine
- Mammary Development and Breast Cancer: A Wnt Perspective
- (2016) Qing Yu et al. Cancers
- Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44+/CD24−/low Stem Cell Phenotype
- (2016) Xuefeng Gao et al. Frontiers in Oncology
- MATE2 Expression Is Associated with Cancer Cell Response to Metformin
- (2016) Sanjana Chowdhury et al. PLoS One
- Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells
- (2015) Jaslyn Sian-Siu Soo et al. APOPTOSIS
- p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells
- (2015) Puyu Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells
- (2015) Rong Sun et al. BIOMATERIALS
- Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy
- (2015) Baek Kim et al. BMC CANCER
- mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
- (2015) Govindasamy-Muralidharan Karthik et al. CANCER LETTERS
- Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
- (2015) Ming Luo et al. CURRENT PHARMACEUTICAL DESIGN
- Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride
- (2015) Meltem Cetin et al. DRUG DELIVERY
- Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers
- (2015) Mette Marie Hougaard Christensen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer
- (2015) CONG FAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
- (2015) Mustafa Kinaan et al. MEDICAL PRINCIPLES AND PRACTICE
- Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)
- (2015) Xiaomin Liang et al. MOLECULAR PHARMACEUTICS
- Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress
- (2015) Patrizia Ferroni et al. Oxidative Medicine and Cellular Longevity
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
- (2015) Deyong Jia et al. Oncotarget
- Metabolic plasticity of cancer stem cells
- (2015) Ming Luo et al. Oncotarget
- Physical Intimacy of Breast Cancer Cells with Mesenchymal Stem Cells Elicits Trastuzumab Resistance through Src Activation
- (2015) Amita Daverey et al. Scientific Reports
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Breast Cancer Recurrence According to Molecular Subtype
- (2014) Hee Jin Shim et al. Asian Pacific Journal of Cancer Prevention
- The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention
- (2014) Beshay N.M. Zordoky et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
- (2014) Ji Ma et al. BMC CANCER
- PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
- (2014) V. N. Kolev et al. CANCER RESEARCH
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
- (2014) Neng Wang et al. CARCINOGENESIS
- Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
- (2014) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the αβγ Heterotrimeric Complex
- (2014) Shumei Meng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells
- (2014) Felicia Leccia et al. Molecular Cancer
- The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
- (2014) X. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy
- (2014) Jennifer Sims-Mourtada et al. MOLECULAR CARCINOGENESIS
- Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined
- (2014) Hyemi Lee et al. PLoS One
- NF-κB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression
- (2014) Shannon M. Smith et al. PLoS One
- Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties
- (2014) Pegah Ghiabi et al. PLoS One
- Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
- (2014) A. Janzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ablation of Breast Cancer Stem Cells with Radiation
- (2014) Steven P. Zielske et al. Translational Oncology
- Human Viruses and Cancer
- (2014) Abigail Morales-Sánchez et al. Viruses-Basel
- De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 Signaling
- (2014) Catherine A. Del Vecchio et al. PLOS BIOLOGY
- Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
- (2014) Natalia Krawczyk et al. Biomed Research International
- Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
- (2014) Tae Hun Kim et al. Biomed Research International
- Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
- (2014) Reema S. Wahdan-Alaswad et al. Hormones & Cancer
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Hyperglycemia as a Risk Factor for Cancer Progression
- (2014) Tae Young Ryu et al. Diabetes & Metabolism Journal
- Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation
- (2013) Karen A Dunphy et al. Cancer Cell International
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- Cancer as a metabolic disease: implications for novel therapeutics
- (2013) T. N. Seyfried et al. CARCINOGENESIS
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- Treatment of Estrogen Receptor-Positive Breast Cancer
- (2013) F. Lumachi et al. CURRENT MEDICINAL CHEMISTRY
- ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel
- (2013) Jun Mao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway
- (2013) GAO YI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Curcumin Suppresses Doxorubicin-Induced Epithelial–Mesenchymal Transition via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells
- (2013) Wei-Chih Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Nonclassical Activation of Hedgehog Signaling Enhances Multidrug Resistance and Makes Cancer Cells Refractory to Smoothened-targeting Hedgehog Inhibition
- (2013) Shamik Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Targeting cancer stem cells to suppress acquired chemotherapy resistance
- (2013) S J Vidal et al. ONCOGENE
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells—an in vitro and in silico study
- (2013) Santhi Latha Pandrangi et al. TUMOR BIOLOGY
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Renal complications of diabetes
- (2012) T. Z. Min et al. BRITISH MEDICAL BULLETIN
- Diabetes and cancer I: risk, survival, and implications for screening
- (2012) Adedayo A. Onitilo et al. CANCER CAUSES & CONTROL
- Breast cancer, side population cells and ABCG2 expression
- (2012) K.M. Britton et al. CANCER LETTERS
- Metformin and Cancer Stem Cells: Old Drug, New Targets
- (2012) F. Bednar et al. Cancer Prevention Research
- Contrasting Hypoxic Effects on Breast Cancer Stem Cell Hierarchy Is Dependent on ER- Status
- (2012) H. Harrison et al. CANCER RESEARCH
- O-Carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells
- (2012) K.S. Snima et al. CARBOHYDRATE POLYMERS
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- (2012) Javier A. Menendez et al. CELL CYCLE
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Breast cancer stem cells
- (2012) Marco A. Velasco-Velázquez et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
- (2012) Petra Hamerlik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures
- (2012) Daniel K Chan et al. Journal of Ovarian Research
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
- (2012) Chang W. Song et al. Scientific Reports
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Breast cancer subtypes and outcome after local and regional relapse
- (2011) E. Montagna et al. ANNALS OF ONCOLOGY
- Chemoresistance to 5-fluorouracil induces epithelial–mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells
- (2011) Weijia Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a
- (2011) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions
- (2011) Bolin Liu et al. CELL CYCLE
- Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
- (2011) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- 14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation
- (2011) Guopei Zheng et al. FEBS LETTERS
- Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species
- (2011) Santhi Achuthan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation
- (2011) D. Yao et al. MOLECULAR CANCER RESEARCH
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
- (2011) Christian M. Metallo et al. NATURE
- Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs
- (2011) Steve Quiros et al. PLoS One
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer
- (2011) Lianhong Li Oncology Letters
- The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
- (2010) Alejandro Vazquez-Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- The Canonical NF- B Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
- (2010) M. Liu et al. CANCER RESEARCH
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Breast cancer stem cells: initiating a new sort of thinking
- (2010) J. I. Herschkowitz Disease Models & Mechanisms
- Drug delivery and nanoparticles: Applications and hazards
- (2010) de Jong International Journal of Nanomedicine
- Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysis
- (2010) Guopei Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer stem cells: problems for therapy?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- Down-Regulation of Rad51 Expression Overcomes Drug Resistance to Gemcitabine in Human Non-Small-Cell Lung Cancer Cells
- (2010) M.-S. Tsai et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cancer Chemotherapy: An Annotated History
- (2010) W.B. Morrison JOURNAL OF VETERINARY INTERNAL MEDICINE
- Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice
- (2010) Shuanglian Li et al. PHARMACEUTICAL RESEARCH
- Diabetes and Cancer
- (2010) T. A. Chowdhury QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb®)
- (2009) Alejandro Vázquez-Martín et al. Clinical & Translational Oncology
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework
- (2009) Bisrat G. Debeb et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function
- (2009) Ying Chen et al. PHARMACOGENOMICS JOURNAL
- Breast cancer chemoresistance: Emerging importance of cancer stem cells
- (2009) Suebwong Chuthapisith et al. SURGICAL ONCOLOGY-OXFORD
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
- (2008) E M Hurt et al. BRITISH JOURNAL OF CANCER
- Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53-Mediated Mouse Mammary Tumors
- (2008) N. Shafee et al. CANCER RESEARCH
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
- (2008) Sonia Correia et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
- (2008) Anne-Pierre Morel et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now